# Autologous Bone Marrow Mesenchymal Stem Cell Transplantation for Chronic Ischemic Stroke

> **NCT02564328** · PHASE1 · UNKNOWN · sponsor: **Southern Medical University, China** · enrollment: 40 (estimated)

## Conditions studied

- Stroke

## Interventions

- **GENETIC:** Intravenous stem cell transplantation

## Key facts

- **NCT ID:** NCT02564328
- **Lead sponsor:** Southern Medical University, China
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2014-11
- **Primary completion:** 2016-11
- **Final completion:** 2017-11
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2015-09-30

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02564328

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02564328, "Autologous Bone Marrow Mesenchymal Stem Cell Transplantation for Chronic Ischemic Stroke". Retrieved via AI Analytics 2026-06-07 from https://api.ai-analytics.org/clinical/NCT02564328. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*